Advertisement

Topics

FDA approves new treatment for prostate cancer with metastasis-free survival endpoint

10:15 EST 16 Feb 2018 | EPM Magazine

The US Food and Drug Administration has approved a new treatment (Elreada) for patients with prostate cancer that is non-metastatic but continues to grow despite being treated with hormone therapy.

Original Article: FDA approves new treatment for prostate cancer with metastasis-free survival endpoint

NEXT ARTICLE

More From BioPortfolio on "FDA approves new treatment for prostate cancer with metastasis-free survival endpoint"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...